Form 4: CalciMedica President and COO Granted Significant Stock Options

CalciMedica, Inc.'s President and COO, Michael J. Dunn, was granted 47,125 employee stock options following stockholder approval of an amended equity incentive plan.

Summary

• Michael J. Dunn, the President and Chief Operating Officer of CalciMedica, Inc. (CALC), was granted 47,125 employee stock options.
• The options have an exercise price of $1.53 per share.
• The grant was initially approved by the Board of Directors on April 23, 2025, and became effective upon stockholder approval of the Amended 2023 Equity Incentive Plan on June 24, 2025.
• These options are immediately exercisable and are set to expire on April 22, 2035.
• Following this transaction, Michael J. Dunn beneficially owns 47,125 derivative securities (employee stock options).

Sentiment

Score: 7

Explanation: The grant of stock options to a key executive is a positive sign of continued executive alignment and retention, reflecting a standard compensation practice that incentivizes long-term performance.

Positives

• The grant of 47,125 employee stock options to President and COO Michael J. Dunn aligns executive incentives with shareholder value.
• Stockholder approval of the Amended 2023 Equity Incentive Plan on June 24, 2025, indicates support for the company's executive compensation strategy and governance.

Future Outlook

The grant of stock options to a key executive indicates continued alignment of management incentives with the company's long-term performance and shareholder interests.

Management Comments

• "The option grant was approved by the Board of Directors of CalciMedica, Inc. (the 'Company') on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the 'Amended 2023 EIP') under which the option was granted."
• "The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."

Industry Context

This Form 4 filing represents a routine insider transaction, specifically an executive compensation event. The grant of stock options is a common practice across industries to incentivize and retain key management personnel, aligning their financial interests with the company's performance.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of options can lead to potential future dilution if exercised, but also aims to align executive performance with shareholder value creation.
• Employees: Reflects the company's ongoing commitment to executive compensation and incentive programs, which can positively influence overall employee morale and retention strategies.

Next Steps

• Potential future exercise of the granted stock options by Michael J. Dunn, subject to the terms and conditions of the option agreement and the Amended 2023 Equity Incentive Plan.

Key Dates

Keywords

CalciMedica, CALC, stock options, executive compensation, insider transaction, Form 4, Michael J. Dunn, equity incentive plan